期刊文献+

白细胞介素-2引起离体大鼠主动脉环舒张及其作用机制 被引量:23

Interleukin-2 induced endothelium-dependent relaxation of rat thoracic aorta
下载PDF
导出
摘要 本文旨在研究白细胞介素 2 (interleukin 2 ,IL 2 )对离体大鼠胸主动脉环收缩张力的作用及其可能机制。采用累积加药法 ,检测IL 2对去氧肾上腺素 (PE)和KCl预收缩的胸主动脉环收缩张力的影响。结果表明 ,IL 2 (1、10、10 0、10 0 0U/ml)对PE (10 μmol/L)预收缩的内皮完整血管环产生浓度依赖性的舒张作用 ,而对KCl(12 0mmol/L)预收缩的血管无作用。去除内皮后 ,IL 2的舒张作用被取消。用一氧化氮合酶抑制剂L NAME (0 1mmol/L)和鸟苷酸环化酶抑制剂亚甲蓝 (10 μmol/L)预处理 ,均可阻断IL 2的舒张血管作用。用环氧合酶抑制剂吲哚美辛 (Indo,10 μmol/L)预处理可阻断IL 2的血管舒张作用。从上述观察结果推论 ,IL 2通过NO Interleukin 2 ( IL 2 ) therapy often results in potentially life threatening side effects including hypotension. However, the mechanism has not been completely elucidated. In order to determine whether IL 2 modifies vascular tone, we investigated the effect of IL 2 on rat thoracic aorta rings and the underlying mechanisms. Effects of IL 2 on the contraction of high KCl and phenylephrine (PE) preconstricted rat thoracic aorta with or without endothelium were determined by organ bath technique. To explore the mechanism, nitric oxide synthase inhibitor L N ( G ) nitroarginine methyl ester ( L NAME), guanylyl cyclase inhibitor methylene blue, and cyclooxygenase inhibitor indomethacin were used. IL 2 (10~1000 U/ml) caused concentration dependent relaxation of aorta rings preconstricted with PE (10 μmol/L) in endothelium intact rings, but had no effect on KCl (120 mmol/L) preconstricted rings. Removal of the endothelium, or pretreatment with L NAME (0 1 mmol/L) or methylene blue (10 μmol/L) or indomethacin (10 μmol/L), inhibited the relaxation of IL 2 . The results indicate that the relaxation by IL 2 in rat aorta ring is endothelium dependent and is possibly mediated by the NO guanylyl cyclase pathway and cyclooxygenase dependent pathway.
出处 《生理学报》 CAS CSCD 北大核心 2003年第1期19-23,共5页 Acta Physiologica Sinica
基金 ThisworkwassupportedbytheNaturalScienceFoundationofZhejiangforTalents (No RC990 38)
关键词 白细胞介素-2 NO 胸主动脉环 内皮 interleukin 2 NO aorta rings endothelium
  • 相关文献

参考文献15

  • 1Shahidi H, Kilbourn RG. The role of nitric oxide in interleukin-2 therapy induced hypotension. Cancer Metastasis Rev 1998;17:119~126.
  • 2Orucevic A, Hearn S, Lala PK. The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice. Lab Invest 1997;76:53~65.
  • 3Fujita S, Puri RK, Yu ZX, Travis WD, Ferrans VJ. An ultrastructural study of in vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2. Cancer 1991;68:2169~2174.
  • 4Rosenberg SA, Lotze MT, Mule JJ. NIH conference. New approaches to the immunotherapy of cancer using interleukin-2. Ann Intern Med 1988;108:853~864.
  • 5Tuttle RS, Boppana DP. Antihypertensive effect of interleukin-2. Hypertension 1990;15:89~94.
  • 6Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109~142.
  • 7Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007~2018.
  • 8Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327(6122):524~526.
  • 9Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 1983;52:352~357.
  • 10Vaandrager AB, de Jonge HR. Signalling by cGMP-dependent protein kinases. Mol Cell Biochem 1996;157(1-2):23~30.

同被引文献168

引证文献23

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部